Bookbot

Controlling Pharmaceutical Risks

Science, Cancer, and the Geneticization of Drug Testing

Paramètres

Pages
224pages
Temps de lecture
8heures

En savoir plus sur le livre

The book delves into the evolution of drug testing since the late 1990s, focusing on the geneticization of carcinogenic risk assessment and pharmaceutical regulation. It explores critical issues in bio-science and medical treatment, questioning what knowledge is deemed essential for assessing carcinogenic risks to humans and examining the processes behind these judgments. Through this analysis, it highlights the implications for patient health and the complexities involved in pharmaceutical regulation.

Achat du livre

Controlling Pharmaceutical Risks, Rachel Ballinger, John Abraham

Langue
Année de publication
2025
product-detail.submit-box.info.binding
(rigide)
Nous vous informerons par e-mail dès que nous l’aurons retrouvé.

Modes de paiement

Personne n'a encore évalué .Évaluer